Citigroup’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-58,800
Closed -$838K 7874
2018
Q3
$838K Buy
58,800
+58,600
+29,300% +$796K ﹤0.01% 3696
2018
Q2
$2K Sell
200
-200
-50% -$2.46K ﹤0.01% 7485
2018
Q1
$5K Sell
400
-1,000
-71% -$14.2K ﹤0.01% 7223
2017
Q4
$20K Sell
1,400
-1,400
-50% -$19.4K ﹤0.01% 6745
2017
Q3
$40K Buy
2,800
+1,800
+180% +$23.3K ﹤0.01% 6112
2017
Q2
$13K Sell
1,000
-500
-33% -$6.07K ﹤0.01% 6447
2017
Q1
$19K Buy
1,500
+500
+50% +$5.93K ﹤0.01% 6287
2016
Q4
$10K Buy
1,000
+500
+100% +$5.7K ﹤0.01% 6757
2016
Q3
$7K Sell
500
-3,500
-88% -$46.8K ﹤0.01% 6687
2016
Q2
$51K Buy
+4,000
New +$53K ﹤0.01% 5562
2016
Q1
Sell
-100
Closed -$2K 7846
2015
Q4
$2K Buy
+100
New +$1.43K ﹤0.01% 7296

Other funds holding MDRX

Citigroup's MDRX Position: Q1 2024 in Review

Citigroup sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 79,265 shares — an estimated $831K sold.

Citigroup first reported a position in MDRX in Q2 2013 and held it in 43 quarters. The position peaked at $18.4M in Q2 2017. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Citigroup reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Citigroup sold 79,265 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $831K.
  • Citigroup first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 43 quarters.
  • Citigroup's Veradigm Inc. Common Stock position peaked at $18.4M in Q2 2017.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Citigroup's 13F filing for Q1 2024, filed 10 May 2024.